SenesTech, Inc.

NasdaqCM SNES

SenesTech, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 1.93

SenesTech, Inc. Price to Sales Ratio (P/S) is 1.93 on January 14, 2025, a -65.89% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

SenesTech, Inc. 52-week high Price to Sales Ratio (P/S) is 7.28 on February 12, 2024, which is 277.53% above the current Price to Sales Ratio (P/S).
SenesTech, Inc. 52-week low Price to Sales Ratio (P/S) is 1.00 on October 07, 2024, which is -47.96% below the current Price to Sales Ratio (P/S).
SenesTech, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 3.00.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: SNES

SenesTech, Inc.

CEO	Mr. Joel L. Fruendt
IPO Date	Dec. 8, 2016
Location	United States
Headquarters	23460 North 19th Avenue
Employees	25
Sector	Health Care
Industries Biotechnology Agriculture Pharmaceuticals

Description

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Key trends

Past 5 years